ACR Highlights… ACR Convergence 2025 Highlights – Spondyloarthritis 24 Nov 202513 Dec 2025 The Assessments in Spondyloarthritis International Society (ASAS) and Spondyloarthritis Research and Treatment Network (SPARTAN) Revised Classification Criteria for Axial Spondyloarthritis: Development and Validation in the Classification of Axial SpA Inception…
ACR Congress Do Not Miss… ACR Convergence 2025: Do Not Miss – Spondyloarthritis 15 Oct 202520 Oct 2025 Piotr Kuszmiersz Piotr is a PhD in Medical Sciences and an Internal Medicine Specialist, currently undertaking his rheumatology training at the Department of Rheumatology and Immunology, Jagiellonian University Medical College…
EULAR 2025 highlights… EULAR 2025 Highlights – Spondyloarthritis: Clinical (therapeutic) 18 Jul 2025 Superior effectiveness and comparable drug retention of anti-TNF therapy versus anti-IL-17A in ankylosing spondylitis after first anti-TNF failure: A propensity score-matched analysis from the Czech ATTRA Registry Abstract format and…
EULAR 2025 highlights… EULAR 2025 Highlights – Spondyloarthritis: Clinical (non-therapeutic) 18 Jul 2025 Impact of Residual Disease on Disease Flares in Axial Spondyloarthritis: A Longitudinal Study in a Dutch Clinical Practice Registry Abstract format and assignment number: Oral presentation OP0097 Date: Wednesday, 11…
ACR Highlights… ACR Convergence 2024 Highlights – Spondyloarthritis: Clinical (therapeutic) 19 Dec 202419 Dec 2024 Nonsteroidal Anti-Inflammatory Drug Use and Incident Hypertension Among Patients with Axial Spondyloarthritis Abstract format and assignment number: Poster 0540 Presenting author: J. Meade Aguilar (USA) Date: Saturday, 16th November 2024…
ACR Highlights… ACR Convergence 2024 Highlights – Spondyloarthritis: Clinical (non-therapeutic) 19 Dec 202419 Dec 2024 Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Psoriatic Arthritis Abstract format and assignment number: Oral presentation 0772 Presenting author: A. Kerschbaumer (Austria) Date: Saturday,…
ACR Congress Do Not Miss… ACR Convergence 2024: Do Not Miss – Spondyloarthritis I – Non-therapeutic 5 Nov 20246 Nov 2024 Miranda van Lunteren PhDMiranda is a post-doctoral clinical researcher and clinical study coordinator at Department of Rheumatology of the Leiden University Medical Center in Leiden. In 2020, she obtained her…
ACR Congress Do Not Miss… ACR Convergence 2024: Do Not Miss – Spondyloarthritis II – Therapeutic 5 Nov 20246 Nov 2024 Clementina López MedinaClementina is a Rheumatologist at the Reina Sofia University Hospital (Spain), a post-doctoral researcher at the Maimonides Institute of Biomedical Research of Cordoba (IMIBIC) and a Tenure Professor…
EULAR 2024 Highlights… EULAR 2024 Highlights – Spondyloarthritis I – non-therapeutic 21 Jul 202421 Jul 2024 Author: Bayram Farisogullari Da Silva et al. (POS0005) compared the spinal symptoms at baseline and after two years in early axial spondyloathritis (axSpA) patients (n = 267) and non-axSpA chronic…
EULAR 2024 Highlights… EULAR 2024 Highlights – Spondyloarthritis II – therapeutic 21 Jul 202421 Jul 2024 Author: Jean-Guillaume Letarouilly Webers et al. (OP0060) investigated which ASDAS cut-off values correspond best with treatment intensification (TI) in practice through the prospective multicentre Dutch registry for patients with SpA…